Clover Corp Ltd (ASX: CLV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Clover Corporation Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $266.30 million
P/E Ratio 46.51
Dividend Yield 0.60%
Shares Outstanding 166.44 million
Earnings per share 0.036
Dividend per share 0.04
Year To Date Return -2.04%
Earnings Yield 2.15%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Clover Corp Ltd (ASX: CLV)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
25 Oct 2021 $0.0050 100.00% Final 16 Nov 2021
07 Apr 2021 $0.0050 100.00% Interim 29 Apr 2021
27 Oct 2020 $0.0250 100.00% Final 18 Nov 2020
29 Oct 2019 $0.0175 100.00% Final 20 Nov 2019
08 Apr 2019 $0.0063 100.00% Interim 30 Apr 2019
29 Oct 2018 $0.0125 100.00% Final 20 Nov 2018
09 Apr 2018 $0.0050 100.00% Interim 01 May 2018
27 Oct 2017 $0.0075 100.00% Final 20 Nov 2017
10 Apr 2017 $0.0025 100.00% Interim 01 May 2017
27 Oct 2016 $0.0050 100.00% Final 21 Nov 2016
11 Apr 2016 $0.0025 100.00% Interim 02 May 2016
28 Oct 2015 $0.0050 100.00% 20 Nov 2015
29 Oct 2014 $0.0050 100.00% 20 Nov 2014
29 Nov 2010 $0.0125 100.00% Final 15 Dec 2010
16 Nov 2004 $0.0100 38.00% 30 Nov 2004

CLV ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Clover Corp Ltd

Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-MegaHi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe, and the Americas. Majority of the revenue is derived from Asia.

CLV Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
19 Jan 2022 $1.68 $0.02 1.20% 37,058 $1.61 $1.68 $1.61
18 Jan 2022 $1.66 $-0.03 -1.78% 165,394 $1.68 $1.69 $1.63
17 Jan 2022 $1.69 $0.03 1.81% 153,007 $1.67 $1.70 $1.65
14 Jan 2022 $1.66 $0.04 2.47% 189,658 $1.62 $1.70 $1.61
13 Jan 2022 $1.62 $-0.07 -4.14% 82,137 $1.68 $1.68 $1.62
12 Jan 2022 $1.69 $0.05 3.05% 51,099 $1.65 $1.69 $1.65
11 Jan 2022 $1.64 $-0.06 -3.53% 82,584 $1.71 $1.71 $1.64
10 Jan 2022 $1.70 $-0.01 -0.58% 15,346 $1.69 $1.71 $1.69
07 Jan 2022 $1.71 $-0.01 -0.58% 15,700 $1.69 $1.72 $1.69
06 Jan 2022 $1.72 $0.00 0.00% 39,975 $1.72 $1.74 $1.65
05 Jan 2022 $1.72 $0.00 0.00% 81,042 $1.63 $1.73 $1.63
04 Jan 2022 $1.72 $0.00 0.00% 69,113 $1.70 $1.73 $1.66
31 Dec 2021 $1.72 $-0.01 -0.58% 15,607 $1.74 $1.74 $1.70
30 Dec 2021 $1.73 $-0.01 -0.58% 12,822 $1.75 $1.75 $1.71
29 Dec 2021 $1.74 $0.01 0.58% 39,492 $1.71 $1.76 $1.70
24 Dec 2021 $1.73 $-0.02 -1.14% 42,323 $1.74 $1.74 $1.70
23 Dec 2021 $1.75 $0.03 1.74% 43,177 $1.72 $1.77 $1.72
22 Dec 2021 $1.72 $-0.01 -0.58% 8,159 $1.73 $1.73 $1.64
21 Dec 2021 $1.73 $0.02 1.17% 11,610 $1.72 $1.73 $1.67

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
13 Dec 2021 Peter Davey Expiry 27 $46,285
As advised by the company. Performance right movement is related to FY22 issue/vesting/lapsing of FY19 performance rights.
353,602 performance rights
13 Dec 2021 Peter Davey Issued 140 $239,680
Issue of securities. 380,749 performance rights
13 Dec 2021 Peter Davey Transfer 68 $116,117
As advised by the company. Exercise / Transfer from Employee Share Plan Trust Account
21 Sep 2021 Simon Green Buy 14 $20,400
On-market trade. Avg Price

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Ian David Glasson Non-Executive Director Feb 2017
Mr Glasson is former CEO of PGG Wrightson based in Christchurch, New Zealand. He was formerly CEO of Gold Coin Group / Zuellig Agriculture which managed a portfolio of animal feed operations and farming ventures throughout South East Asia. Prior to that he was CEO for seven years of Sucrogen. He has also had agribusiness experience with Goodman Fielder and Gresham Rabo, as well as spending the first sixteen years of his career in the oil and gas sector with Esso. Currently, he is Director of Ricegrowers Ltd.
Ms Toni Brendish Non-Executive Director Oct 2020
Ms Brendish was most recently Chief Executive of Westland Milk Products in the South Island of New Zealand. Prior to joining Westland Ms Brendish worked for the Danone Group for 11 years running their Infant Formula and Dairy businesses including Manufacturing sites across Australia and New Zealand, Malaysia and Indonesia. She has also worked for Kimberly-Clark, Colgate Palmolive and other Blue Chip FMCG organisations.
Mr Rupert Anthony Harrington Non-Executive DirectorNon-Executive Chairman Jul 2015
Mr Harrington is an experienced Director with experience in business strategy and M & A. Mr Harrington's earlier career was in operational management in the UK and Australia. His career since 1987 has been in Private Equity where he has delivered results for investors in sectors including: health, technology, industrial services and manufacturing.
Mr Graeme Ambery Billings Non-Executive Director May 2013
Mr Billings was a partner at Coopers and Lybrand and then PricewaterhouseCoopers (PwC) for 24 years. Mr Billings was head of PwC's Melbourne Assurance practice for a number of years as well as Global Leader of PwC's Industrial Products and Manufacturing industry group. Mr Billings brings a range of financial, corporate governance, internal control, commercial and corporate experience to the Company.
Mr Peter J Davey Chief Executive OfficerManaging Director Dec 2014
Mr Davey has held senior management positions within a number of manufacturing and distribution companies operating in competitive and diverse markets. Mr Davey has experience in sales and marketing, and development and implementation of strategies for growth. Mr Davey was formerly Executive Manager AgriProducts and a director of Viterra Australia Limited, responsible for the AgriProducts division that traded in agricultural inputs, fertilizer, seed and wool. In earlier roles, Mr Davey headed the Sales and Marketing divisions of FMP Products and Hi Fert Pty Ltd. Currently, he is Chairman of the Melody Dairies Ltd.
Dr Simon Green Non-Executive Director Oct 2020
Dr Green has 30 years of experience in the biotechnology industry focused on the discovery, development and commercialisation of life saving medicines. He was involved in CSL's global expansion over a 17 year period and held roles as Senior Vice President, Global Plasma R&D and General Manager of CSL's manufacturing plants in Germany and Australia. Simon is currently the founder and CEO of Immunosis Pty Ltd, a start-up diagnostics company. He is also a Partner and investment advisor at BioScience Managers, a healthcare investment firm and serves on the scientific advisory board for Imunexus Pty Ltd.
Mr Andrew Allibon Chief Financial OfficerCompany Secretary May 2021
-
Andrew Allibon Chief Financial OfficerCompany Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Washington H Soul Pattinson & Company Limited 33,713,035 20.26%
Citicorp Nominees Pty Limited 22,113,069 13.29%
J P Morgan Nominees Australia Pty Ltd 14,198,164 8.53%
UBS Nominees Pty Ltd 11,172,125 6.71%
Evelin Investments Pty Limited 7,550,000 4.54%
HSBC Custody Nominees (Aus) Limited 4,352,064 2.61%
National Nominees Limited 4,194,992 2.52%
Incani & Papadoppoulos Super Pty Ltd 2,010,000 1.21%
Citicorp Nom Pty Ltd 1,532,000 0.92%
Mr Peter Howells 1,500,000 0.90%
Custodial Services Limited 1,055,169 0.63%
Mr Garrie Ellice 1,020,000 0.61%
Buttonwood Nominees Pty Ltd 941,281 0.57%
Neweconomy Com Au Nominees Pty Ltd 905,663 0.54%
Mr Pei Yin Foo 900,000 0.54%
Ms Nina Tschernykow 858,881 0.52%
HSBC Custody Nominees (Australia) Limited 786,952 0.47%
Ganesh Super Fund 774,696 0.47%
Connaught Consultants (Finance) Pty Ltd 767,000 0.46%
Bellite Pty Ltd 719,600 0.43%

Profile

since

Note